Test . | Result . |
---|---|
Coagulopathy profile test (reference range) | |
International normalized ratio | 1.0 |
Prothrombin time, seconds (9.5–10.9) | 10.7 |
Partial thromboplastin time, seconds (21.5–26.2) | 22.8 |
Antithrombin III, % normal human pooled plasma (75–125) | 89 |
Homocysteine, μmol/L (<11.4) | 10.9 |
Protein C, % (70–180) | 83 |
Protein S, total, % (70–140) | 143 |
Protein S, free, % (57–171) | 101 |
Dilute Russell’s viper venom time screen, seconds (≤45) | 29 |
Autoimmune profile test (reference range) | |
Antinuclear antibodies (<40) | <40 |
IgA, mg/dL (101–645) | 567 |
IgG, mg/dL (540–1,822) | 1,884 |
IgM, mg/dL (22–240) | 639 |
Tumor markers test (reference range) | |
Carcinoembryonic antigen, ng/mL (<5.0) | 2.6 |
Carbohydrate antigen 19-9, units/mL (<34) | 6 |
Alpha-fetoprotein, ng/mL (<6.1) | 1.2 |
Test . | Result . |
---|---|
Coagulopathy profile test (reference range) | |
International normalized ratio | 1.0 |
Prothrombin time, seconds (9.5–10.9) | 10.7 |
Partial thromboplastin time, seconds (21.5–26.2) | 22.8 |
Antithrombin III, % normal human pooled plasma (75–125) | 89 |
Homocysteine, μmol/L (<11.4) | 10.9 |
Protein C, % (70–180) | 83 |
Protein S, total, % (70–140) | 143 |
Protein S, free, % (57–171) | 101 |
Dilute Russell’s viper venom time screen, seconds (≤45) | 29 |
Autoimmune profile test (reference range) | |
Antinuclear antibodies (<40) | <40 |
IgA, mg/dL (101–645) | 567 |
IgG, mg/dL (540–1,822) | 1,884 |
IgM, mg/dL (22–240) | 639 |
Tumor markers test (reference range) | |
Carcinoembryonic antigen, ng/mL (<5.0) | 2.6 |
Carbohydrate antigen 19-9, units/mL (<34) | 6 |
Alpha-fetoprotein, ng/mL (<6.1) | 1.2 |